Alicia Jackson – Former Deputy Director of the Biological Technologies Office
Dr. Alicia Jackson launched and served as the Deputy Director of the Biological Technologies Office (BTO) at the Defense Advanced Research Projects Agency (DARPA), the Pentagon’s principal engine for disruptive innovation. BTO is DARPA’s technology arm focused on leveraging advances in engineering and information sciences to drive and reshape biotechnology for technological advantage. BTO is responsible for all neurotechnology, human-machine interface, human performance, infectious disease, and synthetic biology programs, totaling approximately $340 million annually. Previously, Dr. Jackson served as a Program Manager at DARPA, creating and managing DARPA’s synthetic biology portfolio as well as programs in unconventional electronic systems.
Earlier in her career, Dr. Jackson served as Professional Staff for energy technology policy for the Chairman of the U.S. Senate Energy Committee. She has a long standing involvement and expertise in technology policy, serving as an Energy Scholar at Georgetown, a Fellow at the National Academies of Science, and co-establishing the Science Policy Initiative at MIT. Dr. Jackson received both her undergraduate and Doctorate degrees in Materials Science and Engineering from MIT.